Overview

Comparison of CHS-1420 Versus Humira in Subjects With Chronic Plaque Psoriasis

Status:
Completed
Trial end date:
2017-03-01
Target enrollment:
Participant gender:
Summary
This is a 3-period study comparing CHS-1420 to Humira in patients with chronic plaque psoriasis.
Phase:
Phase 3
Details
Lead Sponsor:
Coherus Biosciences, Inc.
Treatments:
Adalimumab